Categories
World News

How the US, UK and Canada Will Roll Out the Covid Vaccine

With a coronavirus vaccine approved by the Food and Drug Administration on Friday, the United States became the third highly developed Western country, after the UK and Canada, to approve such a shot, and it is expected to start vaccinating people within a few days becomes.

However, the three countries have very different health systems. And they face different challenges in the race for the vaccine for millions of people.

Here are some similarities and contrasts.

First yes.

The first vaccine to be approved by American regulators and the first to be approved by their British and Canadian counterparts was developed by pharmaceutical giant Pfizer and a small company, BioNTech. It could get European Union approval within a few weeks.

A few others are close, however, notably a vaccine developed by Moderna and the National Institutes of Health, and another by AstraZeneca and the University of Oxford. It could well be that half a dozen or more vaccines will be approved in the coming months.

Throughout 2021, the shots (most vaccinations would require two injections weeks apart) can vary greatly by country, depending on the speed of regulatory approvals, government agreements to buy supplies, and the cost of the vaccines. Even within a country, there can be differences based on how easy it is to distribute and use a particular vaccine.

The Pfizer-BioNTech and Moderna-NIH vaccines are of a new type that has never been used before. They require ultra-cold storage and are more expensive than likely competitors. The Pfizer shot needs to be kept extra cold, at minus 94 degrees Fahrenheit, which most healthcare facilities aren’t equipped for.

In the UK a lot. Not in the United States. Somewhere in between in Canada.

With a strong central government and a National Health Service that covers all people, the UK, which started vaccination last week, is running the process from London. The national government selected the 50 hospitals that should receive the vaccine first and made sure they were prepared. decided how much each would get; and drafted the rules that stipulated the order in which people were entitled to receive them.

The Trump administration has shifted much of the decision-making to the states. The federal government will not need the vaccine distributed to each state based on population size, but some states have complained that they don’t know enough about the regulations.

It will be up to states to decide how the doses will be divided among hospitals, clinics, and ultimately drug stores and doctor’s offices, but first the vaccine will at least get to hospitals with ultra-cold storage.

A committee that advises the Centers for Disease Control and Prevention establishes a list of priorities, starting with medical staff. But this work is still ongoing and the guidelines are not binding. The states are expected to differ somewhat in their approach.

Canada, like Britain, has a universal health system, but like the United States, it has a federal government. The Canadian health system is decentralized and administered by the provinces and territories.

For the distribution of vaccines, the central government plans to work through these regional governments. Ottawa will play a huge role in steering the process.

That remains a bit cloudy.

Canada had ordered enough Pfizer BioNTech vaccine for all of its people, Britain enough for 30 percent, and the United States enough for 15 percent.

However, these numbers reflect shipments that are expected to take months to complete, and Pfizer, like other companies, is struggling to ramp up production. In addition, all three countries have also pre-purchased from other companies, so the pace of vaccine approval could have a significant impact on the pace of adoption.

Updated

Apr. 14, 2020 at 12:21 am ET

This speed is also influenced by the need to equip vaccination sites with proper freezers, staff to prepare the exposures, and enough syringes and protective equipment.

The first deliveries make up a small part of the pre-purchases: 800,000 cans to the UK and an estimated 249,000 to Canada this month.

US officials said they hope to have 40 million doses of the vaccine by the end of the month, which could be optimistic. That would be enough to vaccinate 20 million people.

Rural areas where hospitals are not equipped to keep vaccines at the correct temperatures or do not have the staff to prepare them for injection will not receive Pfizer images. This is more of a barrier in the US and Canada, huge countries with huge, sparsely populated regions, than it is in the UK, which is much more compact.

In Canada, where the military plays a pivotal role in vaccine distribution, the government broadcasts to all ten provinces. The three northern areas will have to wait.

In the US, FedEx and UPS will ship vaccines from distribution centers to all parts of the country. But the holiday season is the busiest time of year for delivery services, which could slow things down.

That is even darker.

The UK, Canada, the United States and the European Union have all followed similar strategies, pre-ordering large numbers of doses – more than enough to vaccinate them all – from multiple manufacturers and hedging their bets in case some of the vaccines are banned or others Manufacturers have production downtimes.

The United States has ordered far fewer doses relative to its population than Canada or the UK, and last summer they turned down an offer to increase their pre-order from Pfizer. Administration officials say the numbers are misleading because the government has signed options to buy far more vaccines if it deems it necessary.

However, given the strong global demand, it is not clear how quickly pharmaceutical companies can fill their orders, let alone additional orders.

Again, the speed of development, approval, and production affects how quickly deliveries get to people. A country that places a bigger bet on one vaccine might be a lot better off than one that is more reliant on another.

Megan Twohey and Ian Austen contributed to the coverage.

Categories
Health

Covid Affected person Examine Reveals Some Profit From an Arthritis Drug

Adding an arthritis drug called baricitinib to Covid treatment regimens that contains the antiviral drug remdesivir can cut recovery times by a day or more, especially for those who are seriously ill, according to a study published Friday.

The results of a government-sponsored clinical trial were released more than three weeks after the Food and Drug Administration received an emergency approval for double treatment. Earlier this month, some experts said they were uncomfortable using medication without a chance to review the underlying data backing their performance. Last month, the World Health Organization also recommended rejecting remdesivir for treating Covid patients as there was no evidence of its use.

In previous press releases, limited results were disclosed showing that hospitalized Covid patients treated with baricitinib and remdesivir recovered one day faster than those who received remdesivir alone.

Some questioned the adoption of the combination treatment because baricitinib came at a high price – which could be around $ 1,500 per patient – and also cited side effects like blood clots. Several doctors also wondered if adding baricitinib would be worth it, since steroids like dexamethasone were cheap and widely available. Both baricitinib and dexamethasone are believed to suppress the excessive inflammation that causes many severe cases of Covid.

The new paper, published in the New England Journal of Medicine, adds some granularity to the results and shows that certain subsets of patients benefited far more from the addition of baricitinib than others. The study included more than 1,000 hospital patients with Covid, all of whom received remdesivir. People who were sick enough to need high doses of supplemental oxygen or non-invasive ventilation recovered eight days faster when baricitinib was included in their medication.

In these groups, “I think the data clearly support a role for baricitinib,” said Dr. Boghuma Kabisen Titanji, an infectious disease doctor at Emory University who pioneered early studies of baricitinib against the coronavirus.

Dr. Titanji also noted that the data suggested that certain patients may be less likely to die or need a ventilator when taking baricitinib in addition to remdesivir. However, like those showing faster recovery times, these results were inconsistent among study participants.

Dr. Lauren Henderson, a pediatric rheumatologist at Boston Children’s Hospital, said she was encouraged by the results and the prospect of another option in the coronavirus treatment arsenal.

She and several other experts added that they may still have a tendency to use dexamethasone as a treatment for seriously ill Covid-19 patients who needed respiratory support.

In contrast to baricitinib, studies have shown that dexamethasone inhibits mortality in seriously ill Covid patients. It’s also inexpensive and easy to get hold of, while baricitinib is more of a specialty drug and may pose barriers to the supply chain, said Dr. Erin McCreary, Infectious Disease Pharmacist at the University of Pittsburgh.

New treatments for Covid-19

Things to know about Covid-19 treatment

Confused By The Terms To Treat Covid-19? Let us help:

    • ACE-2: A protein that sits on the surface of certain types of human cells. The coronavirus has to bind to ACE-2 in order to enter cells.
    • Adverse event: A health problem that occurs in volunteers in a clinical trial with a vaccine or drug. An adverse event is not always caused by the treatment tested in the study.
    • Antibody: A protein produced by the immune system that can attach to a pathogen such as the coronavirus and prevent it from infecting cells.
    • Antiviral drug: A drug that affects the ability of a virus to replicate in cells. The first drug approved in the United States for Covid-19, Remdesivir, is antiviral.
    • Approval, Licensing, and Approval for Emergency Use: Medicines, vaccines and medical devices cannot be sold in the US for no profit approval by the Food and Drug Administration, also known as Licensing. After a company submits the results of clinical studies to the FDA for review, the agency decides whether the product is safe and effective. This process usually takes many months. If the country faces an emergency – like a pandemic – a company can file an application instead Emergency approvalthat can be granted much faster.
    • Compassionate Use: A term used to describe treatments given to seriously ill people even though they have not yet been approved for that use by the Food and Drug Administration.
    • Cytokine storm: An overactive immune system reaction that can lead to massive inflammation and tissue damage. Cytokine storms can be responsible for many of the severe cases of Covid-19, and a number of researchers are testing drugs that may calm them down.
    • Interferon: A molecule of the immune system. Certain types of interferons can cause inflammation in the body while others can contain it. Still other types can stimulate cells to strengthen their defenses against viruses. Researchers are investigating whether treating synthetic interferons can help people fight off the coronavirus.
    • Monoclonal Antibodies: Monoclonal antibodies made in a laboratory mimic the natural antibodies made by the immune system. A number of companies have developed these treatments for Covid-19. President Trump received Regeneron’s antibody treatment soon after the disease was diagnosed.
    • Phases 1, 2 and 3 studies: Clinical trials typically take place in three phases. Phase 1 studies typically involve a few dozen people to determine whether a vaccine or drug is safe. In Phase 2 trials that involve hundreds of people, researchers can try different doses and take more measurements of the vaccine’s effects on the immune system. Phase 3 trials, involving thousands or tens of thousands of volunteers, determine the safety and effectiveness of the vaccine or medicine by waiting to see how many people are protected from the disease it is intended to be used against.
    • Placebo: A substance with no therapeutic effect that is widely used in clinical trials. For example, to see if a vaccine can prevent Covid-19, researchers can inject the vaccine into half of their volunteers while the other half are given a placebo with salt water. You can then compare how many people are infected in each group.
    • Post-market surveillance: The surveillance that occurs after a vaccine or drug has been approved and regularly prescribed by doctors. This typically confirms that the treatment is safe. Rarely, side effects are noted in certain groups of people that were overlooked during clinical trials.
    • Preclinical Research: Studies that take place prior to the start of a clinical trial typically include experiments that test a treatment on cells or animals.
    • Test protocol: A series of procedures that must be performed during a clinical trial.
    • Retrospective study: A study that analyzes data collected in the past to determine how effective a treatment is. Retrospective studies can provide useful information, but they are not as definitive as randomized clinical studies.
    • Spike protein: A protein that sits on the surface of coronaviruses. The spike protein binds to the ACE-2 receptor on human cells using a region called the receptor binding domain (RBD). As soon as the protein accumulates, the virus can enter the cell. Many vaccines and monoclonal antibody treatments are designed to stick to the tip.
    • Standard of care: A treatment that is accepted by medical experts as an appropriate method to treat a specific type of disease. Once a standard for treating a disease is established, new experimental treatments are usually tested against it rather than a placebo.

Several experts pointed to another study by the National Institutes of Health that seeks to directly compare two combination treatment regimens: one in which hospital patients receive remdesivir and baricitinib, and one in which remdesivir is paired with dexamethasone. Dr. McCreary also noted the importance of studying patients receiving both baricitinib and dexamethasone “to see if there is any incremental benefit.”

Dr. Andre Kalil, an infectious disease doctor at the University of Nebraska Medical Center and lead researcher on the new paper, noted that while dexamethasone had already become a widely accepted treatment for Covid-19, the steroid still needed further study. He cited “a variety of serious safety issues” with the drug that warranted thorough investigation.

Like other steroids, dexamethasone, which largely reduces inflammation, can be associated with a variety of undesirable side effects, including worsening conditions like diabetes or osteoporosis.

Categories
Health

Google search panels deal with misinformation about Covid vaccines

Google logo of the American multinational technology company at Googleplex, the corporate headquarters complex of Google and its parent company Alphabet Inc.

Alex Tai | SOPA pictures | LightRocket | Getty Images

LONDON – Google launched new bulletin boards in search results on Thursday to counter false claims about the coronavirus vaccines.

The internet giant said in a blog post that the feature would first be rolled out in the UK, where people started vaccinating people with the Covid-19 vaccine developed by Pfizer and BioNTech.

The feature will be rolled out in other countries once they start approving vaccines.

Google has been updating its platforms for several months with features that display Covid-related data from governments and health agencies such as the World Health Organization and the Centers for Disease Control to combat misinformation about the virus.

The YouTube video sharing service launched so-called knowledge panels on the virus back in March and is said to have been viewed 400 billion times. YouTube updated its guidelines in October to remove videos that made false claims about coronavirus vaccines.

A screenshot with Google’s new knowledge boards on coronavirus vaccine search results.

Ryan Browne | CNBC

It’s not clear how effective bulletin boards are in preventing internet users from believing misinformation about coronavirus. Fake conspiracy theories about the disease have spread like wildfire across social media platforms this year.

Tackling misinformation about the vaccines will be a mammoth task for tech giants like Google, Facebook and Twitter as governments around the world seek to immunize people against the disease.

Last week, Facebook announced it was removing false claims about Covid vaccines. This is part of his policy on posts that could result in “imminent physical harm”. Twitter has yet to say whether it will ban such posts.

Aside from introducing new features, Google announced on Thursday that it was earmarking $ 1.5 million to fund fact-checking research and create a hub for journalists to give them access to “scientific expertise and research updates.” to facilitate vaccines.

Categories
Business

Trump doesn’t put on masks at Military-Navy recreation regardless of Covid considerations

United States President Donald Trump joins West Point cadets during the Army Navy soccer game at Michie Stadium on December 12, 2020 in West Point, New York.

Brendan Smialowski | AFP | Getty Images

President Donald Trump did not wear a mask for some time as he stood near West Point cadets and midshipmen of the Naval Academy who all wore masks during the Army-Navy soccer game on Saturday.

Trump, who was hospitalized in early October after contracting the coronavirus, also did not wear a mask when he directed the coin toss before the game at the U.S. Military Academy in West Point, New York.

Nor did the umpire of the game during the coin toss, which Navy won by properly calling the tails.

The 121st meeting of the two service academies on the soccer grate came after coronavirus deaths hit a daily record of 3,309 Americans, bringing the US death toll this year to over 297,000 from the pandemic. As of Saturday, the number of coronavirus cases in the US hit 16 million so far this year.

After the coin toss, Trump entered the stands on the Army side of Michie Stadium, where he was surrounded by cadets wearing masks.

The Lame Duck President put on a mask in the stands at some point in the first quarter of the game, where he was standing not far from a cadet in an army mascot outfit.

But the president, who announced emergency approval for a coronavirus vaccine on Friday night, had his mask off when he left the stands.

And he wasn’t wearing a mask when he went out into the stands and stood with the Navy Midshipmen. With Trump in the stands was Mark Meadows, Chief of Staff of the White House, who was also not wearing a mask. Coronavirus was diagnosed at Meadows in early November.

U.S. President Trump stands among U.S. Army cadets as he participates in the Army-Navy annual college football game at Michie Stadium in West Point, New York, United States on December 12, 2020.

Tom Brenner | Reuters

Twitter users condemned the commander in chief for failing to set a good example to the cadets and midshipmen at the game, the 121st soccer meeting between the two service academies.

“Trump was the only person in the Army Navy game who wasn’t wearing a mask! Protect our troops, damn it!” Tweeted one person.

Another wrote: “He only cares about himself.”

Trump’s failure to wear a mask, even when federal health officials have urged all Americans to do so, is consistent with his near-constant refusal to wear face-covering during the Covid-19 pandemic, even when dozens of people in his orbit are positive for coronavirus have been tested.

In addition to Meadows, Trump’s wife, sons Barron and Donald Trump Jr., campaign managers, the White House press secretary, the Secretary for Housing and Urban Development, and the chair of the Republican National Committee are among those who have had Covid in the past few months.

Trump’s personal attorney Rudy Giuliani, who oversees botched legal efforts of his campaign to undo Joe Biden’s presidential election victory, was discharged from a Washington, DC hospital a few days ago after testing positive for the coronavirus. Previously, Giuliani’s son Andrew, a special assistant to Trump in the White House, had a coronavirus.

Trump left the game early before the second quarter ended.

He is expected to leave the White House on January 20, despite his desperate legal and rhetorical efforts to deny a Biden victory on Monday in the electoral college.

Biden is expected to win 306 votes, 36 more than needed to win the presidential race.

When Trump was on his way to West Point on Saturday, a federal judge threw back his lawsuit to invalidate Biden’s victory in the Wisconsin popular election.

On Friday, the US Supreme Court refused to allow the Texas Attorney General to file a lawsuit directly with that court to reverse election results that show victories for Biden in Georgia, Michigan, Pennsylvania and Wisconsin.

Categories
Business

CDC panel recommends Pfizer Covid vaccine for folks 16 years and older, clearing pivotal hurdle

CDC headquarters in Atlanta

Elijah Nouvelage | Bloomberg via Getty Images

A key panel from the U.S. Centers for Disease Control and Prevention unanimously voted on Saturday to recommend Pfizer-BioNTech’s Covid-19 vaccine for people aged 16 and over. This cleared another crucial hurdle for the drug before the vaccinations begin in the coming days.

The CDC’s Advisory Committee on Immunization Practices, an external group of medical experts advising the agency, voted 11-0 in favor of recommending the vaccine for use in people aged 16 and over under the Food and Drug Administration’s emergency clearance. Three members withdrew due to conflicts.

The recommendation will now be sent to CDC Director Dr. Robert Redfield who must sign out before vaccinations can begin. A CDC spokesman was not immediately available for comment on when Redfield would sign the recommendation.

“This Covid-19 vaccine gives us hope,” said Veronica McNally, ACIP member and assistant dean of experiential education at Michigan State University College of Law. “It’s important to remember that while this vaccine was being developed at an incredible pace and incorporating new technologies, it went through all appropriate channels of regulation and the approval process was transparent.”

Dr. Beth Bell, an ACIP member and clinical professor of global health at the University of Washington, said she recognized people’s concern about this vaccine and new vaccines in general, but added that they were “safely” taking this vaccine when it is she will turn.

“I believe the process we have used here at ACIP to make this decision is transparent, science-based, fair-minded, and for this moment the absolute best we can do,” said Bell .

The vote marked the end of an hour-long meeting during which ACIP members heard presentations from CDC officials on clinical considerations for those vaccinated under the emergency license.

Dr. Sarah Mbaeyi, a CDC doctor, told the agency during a presentation that vaccines should be offered to people “regardless of a history of previous symptomatic or asymptomatic” coronavirus infection. However, Mbaeyi told the panel that a diagnostic or antibody test is not recommended to help decide whether someone should receive the vaccine.

More studies on the vaccine’s safety in pregnant women are ongoing, Mbaeyi said. However, if a pregnant woman is part of a group that is prioritized for the vaccine, Mbaeyi said she could opt for vaccination after making an informed decision with a health care provider.

The public was also asked to share comments and concerns about the vaccine and its dissemination. Claire Hannan, the executive director of the Association of Immunization Managers, told the committee that there needs to be more precise guidance on who is considered an essential worker, as definitions differ across the US.

On December 1, the group voted 13-1 for healthcare workers and residents of long-term care facilities to receive the first doses of vaccine once released for public use. The ACIP emergency meeting, postponed from Sunday to Saturday, followed the FDA’s decision to give Pfizer’s vaccine emergency approval on Friday evening.

Categories
Health

Tragedy, Covid isolation, and psychological well being

Tony Hsieh, CEO von Zappos.com

Getty Images

Tony Hsieh schien alles zu haben.

Hsieh startete die in Las Vegas ansässige Schuh-E-Commerce-Plattform Zappos und verkaufte sie 2009 für 1,2 Milliarden US-Dollar an Amazon – die größte Akquisition in der Geschichte von Amazon zu dieser Zeit. Er war ein Unternehmer, der sich durch seinen unkonventionellen Führungsstil auszeichnete, der die Kultur über alles stellte und sich über die Unternehmenshierarchie lustig machte. Im Jahr 2010 veröffentlichte er ein Buch, das seinen eigenen Führungsstil in einem Buch kodifizierte: “Glück bringen: Ein Weg zu Gewinn, Leidenschaft und Zweck”. Er war auch dafür bekannt geworden, 350 Millionen Dollar für die Wiederbelebung der Innenstadt von Las Vegas zu spenden.

In einem First-Person-Tell-All-Artikel, den Hsieh 2010 im Wirtschaftsmagazin Inc schrieb und veröffentlichte, beschreibt Hsieh den Flug nach Seattle, um sich mit Bezos zu treffen, bevor der Deal formalisiert wurde.

“Ich gab ihm meine Standardpräsentation über Zappos, in der es hauptsächlich um unsere Kultur geht. Gegen Ende der Präsentation begann ich über die Wissenschaft des Glücks zu sprechen – und wie wir versuchen, sie zu nutzen, um unseren Kunden und Mitarbeitern besser zu dienen”, so Hsieh schrieb.

Er fuhr fort: “Aus dem Nichts sagte Jeff: ‘Wussten Sie, dass die Leute sehr schlecht vorhersagen können, was sie glücklich machen wird?’ Das waren die genauen Worte auf meiner nächsten Folie. Ich stellte sie auf und sagte: “Ja, aber anscheinend können Sie PowerPoint-Folien sehr gut vorhersagen.”

Der Moment liest sich jetzt wie ein Vorbote der kommenden schweren Zeiten.

Am 18. November starb Hsieh im Alter von 46 Jahren an den Folgen einer Rauchinhalation, nachdem er in einem kleinen Lagerraum hinter einem Strandhaus in New London, Connecticut, aus einem Brand gerettet worden war. Offiziell wurde der Tod von Connecticut als Unfall gewertet Büro des Chefarztes. Berichten zufolge wurde mindestens ein Notarbeiter belauscht, der sagte, er habe sich im Inneren verbarrikadiert.

Die Jahre vor Hsiehs frühem Tod umfassten unersättlichen Alkohol- und Drogenkonsum, extremes “Biohacking”, einschließlich der Frage, wie lange er ohne Essen und Urinieren auskommen konnte, eine Besessenheit mit Feuer und Kerzen und den Kauf von Häusern in Park City, Utah, und das Bezahlen Laut Berichten in Forbes und im Wall Street Journal verdoppeln die Menschen ihr höchstes Traumgehalt, um auf den von Hsieh gekauften Grundstücken zu leben, wenn sie mit ihm zufrieden wären.

Auch ohne genau zu wissen, was in diesem Schuppen in Connecticut passiert war, hatte Hsieh eindeutig Angst. Experten für psychische Gesundheit warnen davor, dass die anhaltende Covid-Pandemie das Gefühl der Isolation und Einsamkeit verstärken kann, und bieten Tipps und Ressourcen, um Hilfe für sich selbst oder Ihre Angehörigen zu suchen.

Bei Einsamkeit geht es nicht nur um Nähe

Die Abwesenheit von Menschen in der Nähe definiert keine Einsamkeit, sagt C. Vaile Wright, Senior Director für Innovation im Gesundheitswesen in der Praxisdirektion der American Psychological Association.

“Einsamkeit ist wirklich das Gefühl, niemanden zu haben, der sich um dich kümmert. Das ist etwas anderes als nur allein zu sein. Menschen können allein sein und sich nicht einsam fühlen”, sagt Wright gegenüber CNBC.

“Viele von uns sind aufgrund von Covid physisch isoliert, aber es ist immer noch von entscheidender Bedeutung, soziale Verbindungen aufrechtzuerhalten, die sinnvoll sind und diesem Gefühl der Einsamkeit entgegenwirken.” Das kann Telefonanrufe, Videoanrufe und Spaziergänge mit Freunden im Freien bedeuten, aber es kann auch bedeuten, Pflegepakete zu senden oder Briefe zu schreiben, sagt Wright.

Wenn ein Freund oder eine geliebte Person isoliert, ist das eine “wirklich kritische rote Fahne”, sagt Wright.

“Das Markenzeichen wäre, wenn jemandes Symptome seine Fähigkeit beeinträchtigen, auf signifikante Weise zu funktionieren”, sagt Wright gegenüber CNBC. “Sie sind nicht in der Lage zu arbeiten, nicht einmal von zu Hause aus zu arbeiten oder zur Schule zu gehen. Sie haben aufgehört, auf sich selbst aufzupassen, was so aussehen kann, als würden sie nicht duschen, nicht essen, nicht schlafen oder sie können sich nicht um ihre Lieben kümmern.”

Inmitten der Coronavirus-Pandemie, in der es zur Norm geworden ist, sich von anderen Menschen fernzuhalten, um sich körperlich gesund zu halten, kann sich die Isolation als eine Person manifestieren, die nicht zu regelmäßig geplanten virtuellen Terminen erscheint und keine Texte gemäß ihrer üblichen Trittfrequenz zurückgibt oder Substanzen missbraucht .

Es ist schwieriger, gefährliche Einsamkeit zu erkennen, wenn alle aufgefordert werden, getrennt zu bleiben, sagt Wright.

“Es wird für uns noch wichtiger, alles zu tun, um Menschen zu erreichen, in der Regel diejenigen, von denen wir wissen, dass sie anfälliger und hartnäckiger sind”, sagt sie gegenüber CNBC. Manchmal erreichen besorgte Freunde und Angehörige nicht, weil sie nicht wissen, wie sie die Situation beheben können, sagt Wright, aber selbst wenn sie nur Bedenken äußern, kann dies eine große Hilfe sein.

“Normalerweise suchen die Leute nur jemanden, der sich um sie kümmert, der hören will, was sie durchmachen, ihre Erfahrungen validiert und dann vielleicht bei der Problemlösung hilft”, sagt Wright. “Aber ich denke wirklich, wir müssen uns nur darum bemühen, offene, nicht wertende Fragen zu stellen, wie es den Menschen geht.”

Laut Wright gibt es folgende gute und einfache Möglichkeiten, um zu sagen, was zu sagen ist, wenn Sie besorgt sind, dass ein Freund oder ein geliebter Mensch in Gefahr ist: “Ich mache mir Sorgen um Sie. Können Sie mir sagen, wie es Ihnen geht?” Oder: “Ich habe bemerkt, dass Sie nicht wissen, wann Sie Texte zurückgeben, und ich frage mich, ob es Ihnen gut geht.” Jemanden, der sich einsam fühlt, für ihn da zu lassen, ist der Schlüssel, sagt sie.

Warum Einsamkeit schlecht für unsere Gesundheit ist

“Wissenschaftler aus verschiedenen Disziplinen argumentieren, dass Menschen unsere soziale Spezies sind, und deshalb mussten wir uns im Laufe der Menschheitsgeschichte auf andere verlassen”, so Julianne Holt-Lunstad, Professorin für Psychologie und Neurowissenschaften an Brigham Young University erzählt CNBC. “Ein Teil einer Gruppe zu sein war mit Sicherheit und Effizienz verbunden. Es ist also sehr bedrohlich, außerhalb einer Gruppe oder allein zu sein.”

Soziale Isolation bedeutet, “alles ganz alleine bewältigen und bewältigen zu müssen”, sagte Hold-Lunstad. “Es wurde argumentiert, dass sich unser Gehirn im Wesentlichen so entwickelt hat, dass es die Nähe zu anderen erwartet. Wenn wir dies nicht tun, wenn uns diese Nähe zu anderen fehlt – und wir anderen besonders vertrauen -, entsteht ein Zustand der Wachsamkeit und Bedrohung Unser Gehirn.”

Wenn sich das Gehirn in einem “erhöhten Alarmzustand” befindet, sendet es auch Signale an den menschlichen Körper, und das “kann Dinge wie erhöhten Blutdruck und Herzfrequenz, zirkulierende Stresshormone und Entzündungen umfassen”, sagt sie. “Diese Informationen wurden wiederum mit einer Reihe chronischer Krankheiten in Verbindung gebracht – sie wurden mit Depressionen in Verbindung gebracht und interessanterweise sogar mit einer höheren Anfälligkeit für Viren.”

Die Forschung von Hold-Lunstad hat gezeigt, dass die Wahrnehmung der Unterstützung ausreicht, um “diese physiologischen Reaktionen zu dämpfen”, die mit dem Gefühl der Isolation verbunden sind. Ihre Laboruntersuchungen zeigen geminderte Reaktionen auf Stress, selbst wenn die Personen, die den Studienteilnehmern ein Gefühl der Unterstützung geben, nicht im Raum sind.

“Die Wahrnehmung der Verfügbarkeit von Support ist also enorm”, sagt Hold-Lunstad. “In einer meiner Studien, in denen wir Daten von über 300.000 Teilnehmern weltweit hatten, stellten wir fest, dass die Wahrnehmung von Unterstützung mit einer um 35% erhöhten Überlebenschance verbunden war.”

Es hilft auch, freundliche Dinge für andere zu tun. Hold-Lunstad hat gerade eine Studie zwischen Juli und September mit etwas mehr als 4.200 Studienteilnehmern zwischen den USA, Großbritannien und Australien abgeschlossen. Es zeigte sich, dass diejenigen, die zufällige freundliche Handlungen für Nachbarn vollzogen, ob sie einen Rasen mähten oder Informationen darüber austauschten, wo sie Backhefe fanden, “in den vier Wochen eine signifikante Verringerung der Einsamkeit zeigten”.

Auch Jugendliche und junge Erwachsene haben Probleme

Laut der Umfrage der American Psychological Associations Stress in America aus dem Jahr 2020 geben 67% der Erwachsenen der Generation Z (im Alter von 18 bis 23 Jahren) an, dass das Coronavirus “eine Planung für ihre Zukunft unmöglich macht”, eine Statistik, die die Psychologin Dr. Mary Alvord für CNBC hervorhob. Und die Hälfte der Teenager der Generation Z (13-17 Jahre) gibt an, dass die Pandemie laut dem Bericht “ihre Pläne für die Zukunft ernsthaft gestört hat”.

Und während das Coronavirus und die daraus resultierenden Veränderungen im Leben eine massive Hürde darstellen, gibt es laut Alvord auch andere Stressfaktoren, darunter “Rassenunruhen, Fehlinformationen, Spaltung der Bevölkerung und der Familien, finanzieller Stress der Familien, Trauer und Verlust nicht nur durch COVID-Todesfälle und Krankheiten, aber auch von Arbeitsplätzen und Unternehmen verloren. ” Es gibt auch die ständige Unsicherheit in Bezug auf die Schule und ob sie persönlich, online oder in einer Kombination aus beiden stattfinden wird, sagt Alvord.

“Übergangsriten werden verpasst”, sagte Alvord. “Sport-, Theater- und Clubaktivitäten werden verpasst oder virtuell abgehalten, aber nicht gleichbedeutend mit persönlichen Aktivitäten.”

“Obwohl sie alt genug sind, um die Nachrichten zu lesen und zu hören, sind sie nicht immer in der Lage, alle Ereignisse und Probleme im Blick zu behalten”, sagte Alvord, der auch Mitautor von “Conquer Negative Thinking for Teens: A Workbook to” ist Brechen Sie die neun Gedankengewohnheiten, die Sie zurückhalten. ” “Wenn Sie” katastrophal “wie” Was ist, wenn dies passiert “und” Was ist, wenn ich nicht x “hören, kann dies bedeuten, dass die Angst überhand nimmt und die Perspektive verringert wird. Fragen Sie den Teenager oder jungen Erwachsenen:” Was sind? ” die realistischen Chancen, dass etwas wirklich Schlimmes passiert: “Können sie damit umgehen?” und “Was würden sie einem Freund sagen, der sich über dieselben Gedanken Sorgen macht?”

Ähnlich wie bei den oben genannten Warnzeichen für Erwachsene sind “plötzliche Änderungen des Verhaltens, des Schlafes, des Essverhaltens oder der Verschiebung oder Abschaltung von Freunden und Familie sowie negative Selbstaussagen” wichtige Warnzeichen, die junge Erwachsene nicht bewältigen, sagt Alvord.

Eltern “können Bewältigung modellieren”, sagt Alvord gegenüber CNBC und gibt Teenagern und jungen Erwachsenen eine Vorlage für den Umgang mit Stress. Sie können dies tun, indem sie angesichts von Stress und ungeplanten Straßensperren ruhig bleiben. Oder: “Wenn sie nicht ruhig sind, können sie etwas sagen wie: ‘Ich bin so frustriert, weil x gerade passiert ist. Aber ich werde ein paar tiefe Atemzüge machen, mich beruhigen und die nächsten Schritte herausfinden. Ich werde darüber nachdenken 3 Dinge, die ich gegen diese Situation tun kann ‘”, sagt Alvord. “‘Ich kann nicht alles kontrollieren, was vor sich geht, aber ich kann diesen Teil davon kontrollieren und ich denke über einen Plan nach, um damit umzugehen.'”

Professionelle Ressourcen

Wenn jemand, den Sie kennen, in verzweifelter Gefahr ist, rufen Sie 911 an und schicken Sie einen Arzt zu sich nach Hause, sagt Wright.

Eine weitere wichtige Ressource ist die National Suicide Prevention Lifeline unter 1-800-273-TALK (8255).

Wenn ein Freund oder eine geliebte Person in Gefahr ist, sich selbst zu verletzen, ist es in Ordnung, direkt zu sein, sagt Elinore F. McCance-Katz, stellvertretende Sekretärin für Gesundheit und menschliche Dienste für psychische Gesundheit und Substanzgebrauch, die Agentur in der Abteilung der Bundesregierung Health and Human Services arbeiten an der Verbesserung der Verhaltensgesundheit, wodurch die Hotline finanziert wird. Sagen Sie ihnen, dass sie die Hotline 24 Stunden am Tag anrufen können, sagt sie.

“Teilen Sie auf unkomplizierte und unterstützende Weise mit, was Sie bemerken, und bieten Sie an, darüber zu sprechen (z. B.” Sie waren in den letzten Wochen sehr traurig “)”, sagt McCance-Katz gegenüber CNBC über einen Abteilungssprecher. “Seien Sie bereit, die direkte Frage sanft zu stellen: ‘Haben Sie darüber nachgedacht, sich selbst zu verletzen?’ Sie werden die Idee nicht in den Kopf Ihres geliebten Menschen stecken, sondern viele sehen dies als einen Weg, die Tür für das Gespräch zu öffnen. Es beseitigt das Stigma, das mit Selbstmordgedanken verbunden ist, und die Schande, die man empfinden kann, wenn sie sie haben . “

Wenn Sie sich Sorgen um einen Freund oder einen geliebten Menschen machen und dringend Hilfe oder Anleitung benötigen, können Sie auch die National Suicide Prevention Lifeline anrufen, sagt McCance-Katz.

Wenn ein geliebter Mensch oder Freund Anzeichen einer Verschlechterung der psychischen Gesundheit zeigt, kann eine professionelle Therapie erforderlich sein. “Die meisten Therapeuten haben sich der Telegesundheit zugewandt, dh Videokonferenzen oder nur dem Telefonieren, und wir wissen, dass beide Methoden genauso effektiv sind wie von Angesicht zu Angesicht [therapy]”, Sagt Wright gegenüber CNBC. Die Suche nach einem Therapeuten kann bei Ihrem Hausarzt oder Ihrer Versicherungsgesellschaft beginnen. Wenn Sie keinen Hausarzt oder keine Versicherung haben, können Sie zunächst Freunde und Familie nach ihren Empfehlungen fragen oder weiter suchen ein Therapeuten-Locator im Internet, wie der von Psychology Today.

Grundsätzlich ist es schwierig, jemandem zu helfen, der mit psychischen Problemen zu kämpfen hat. “Es kann eine Herausforderung sein, wenn Sie der geliebte Mensch oder der Freund sind, weil Sie oft nicht viel unter Ihrer Kontrolle haben, außer zu erreichen, Ressourcen anzubieten, sich selbst als Ressource auszuschalten”, sagt Wright gegenüber CNBC. “Bis zu einem gewissen Grad muss es die Person selbst sein, die sich bemüht. Und das ist wirklich herausfordernd.”

Categories
World News

Trump indicators funding invoice amid Covid reduction push

President Donald Trump signed a week-long government funding extension Friday as Congress rushed to secure coronavirus spending and relief.

The Senate passed the measure in a vote earlier in the day, and the House approved it this week. Funding would have expired on Saturday if Washington hadn’t passed a spending plan.

The law will fund the government until December 18th. Congressional leaders hope to have both a year-round funding package and pandemic aid approved by then. You have tried to reach an agreement on both fronts.

The appropriators have agreed on a $ 1.4 trillion price for the legislation to keep the government running through September 30, 2021. However, they have not agreed on exactly where the money should go.

Despite the most frantic effort in months to develop a coronavirus bailout, Congress must resolve several major disputes to reach an agreement. Millions of Americans await help as an uncontrolled outbreak ravages communities across the country, creating hunger that has not been seen for years.

If the legislature cannot pass relief laws in the coming days, around 12 million people will lose unemployment benefits the day after Christmas. An eviction moratorium and provisions for family leave introduced at the beginning of this year will also expire at the end of December.

Two senators, the independent Vermont-based Bernie Sanders and the Missouri Republican Josh Hawley, threatened to block the spending measure when they urged Congress to send more aid to Americans. Legislators wanted to vote on a proposal to send another direct payment of up to $ 1,200 for individuals and $ 500 per child.

Sanders said he decided not to object to government funding on Friday but would do so next week if Congress didn’t seek more relief.

“We are more hungry in America today than ever before in the modern history of this country,” said the senator when pressing for direct payments.

For months, Congress failed to provide more aid to Americans, despite ongoing health and economic crises. A GOP-backed proposal to give businesses immunity from coronavirus-related lawsuits and a plan to send more aid to state and local governments backed by Democrats and many Republicans remain the biggest sticking points in reaching a settlement .

Democrats have also criticized the fact that the recent $ 916 billion aid offer from the White House, blessed by GOP congressional leaders, does not include additional federal unemployment insurance funds. It has a direct payment of $ 600, half the total of the March stimulus checks approved by Congress.

Democrats have put their weight behind a $ 908 billion package put together by a non-partisan group. The measure would include unemployment benefit of $ 300 per week but no direct payments.

Subscribe to CNBC on YouTube.

Categories
Health

FDA advisory panel meets at this time to vote on whether or not to advocate approval of Pfizer’s Covid vaccine

[The stream is slated to start at 9 a.m. ET. Please refresh the page if you do not see a player above at that time.]

A panel from the Food and Drug Administration will meet Thursday to vote on whether to recommend Pfizer and BioNTech’s emergency approval of the coronavirus vaccine.

Prior to voting by the Agency’s Advisory Committee on Vaccines and Related Biological Products, the independent panel of medical experts will evaluate the Pfizer clinical trial data and provide their opinion on the vaccine, including whether the benefits outweigh the risks in an emergency .

The FDA is not required to follow the advice of the advisory group, but it often does.

A recommendation from the advisory committee is the final step before the FDA is likely to give final OK to the distribution of the potentially life-saving doses in the United States. The vaccine would be the first to be approved for use in the United States

Read CNBC’s live updates for the latest news on the Covid-19 outbreak.

Categories
Business

NY Gov. Cuomo holds a press briefing as state prepares to distribute Covid vaccine

[The stream is slated to start at 11:30 a.m. ET. Please refresh the page if you do not see a player above at that time.]

New York Governor Andrew Cuomo will hold a press conference Friday on the coronavirus pandemic as the state prepares to receive a Covid-19 vaccine, which could be approved and dispensed in the coming days.

Cuomo is represented by Rep. Hakeem Jeffries (D-NY), Rep. Grace Meng (D-NY), Rep. Karen Bass (D-CA), Rep. Joaquin Castro (D-TX) and Rep. Deb Haaland (D- NY) accompanies D-NM).

The Democratic governor has announced that New York is expected to receive an initial allocation of 170,000 doses of Pfizer’s vaccine once the U.S. Food and Drug Administration approves the shots. New York could get the cans this weekend, Cuomo’s office said in a press release on Wednesday.

Meanwhile, New York is considering restricting indoor eating if state hospitals continue to be overcrowded with Covid-19 patients. Cuomo said Monday if New York hospital stays don’t stabilize within five days, the state could shut down indoor dining in the city as early as next week.

Read CNBC’s live updates for the latest news on the Covid-19 outbreak.

Categories
Health

Pfizer’s Covid vaccine permitted by FDA for emergency use

The Food and Drug Administration has approved Pfizer and BioNTech’s coronavirus vaccine for emergency use. This is a monumental turning point in the one-time pandemic that killed nearly 300,000 Americans and devastated the US economy in less than a year.

FDA chief scientist Denise Hinton told Pfizer in a letter Friday that she approved the company’s emergency use of the vaccine.

President Donald Trump called it a “medical miracle” in a video tweet. “We delivered a safe and effective vaccine in just 9 months,” Trump said. “This is one of the greatest scientific achievements in history.”

Dr. Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research, said the decision “promises to change the course of this pandemic in the United States.” “With the science guiding our decision-making, the available safety and efficacy data to support the approval of the Pfizer-BioNTech COVID-19 vaccine because the known and potential benefits of the vaccine significantly outweigh the known and potential risks,” he said.

FDA approval for the emergency will now boost the federal government’s distribution of the potentially life-saving doses to 64 states, territories and major cities across the country. The government plans to distribute 2.9 million doses of the vaccine within 24 hours, followed by another 2.9 million doses 21 days later, for patients to receive their second shot, General Gustave Perna, who runs the logistics for the Operation Warp vaccination program Speed ​​monitored by President Donald Trump said Wednesday. Pfizer’s vaccine requires two doses three weeks apart.

The vaccine couldn’t come at a more crucial time. Hospitals in the U.S. already have higher numbers of Covid patients than ever before, and the country’s outbreak is poised to break even grimmer records. According to a CNBC analysis of the Johns Hopkins University data, the US reported 3,124 new Covid-19 deaths on Wednesday, the pandemic’s deadliest one-day record to date. The director of the Centers for Disease Control and Prevention, Dr. Robert Redfield, warned earlier this month that the next few months of the pandemic would be “some of the most difficult in the history of this country’s public health.”

Initial doses of the Pfizer vaccine will be limited as production begins. Officials predict it will be months before everyone in the US who wants to be vaccinated is vaccinated. Pfizer has announced that it will ship 50 million doses of vaccine this year, enough to vaccinate 25 million people. The vaccine is expected to be distributed in phases where the most critical U.S. workers and vulnerable people receive it first. The CDC has given states an outline recommending that priority be given to health workers and nursing homes first. However, states may distribute the vaccine at their own discretion.

An emergency permit, or EEA, is not the same as a full permit, which can typically take months. Pfizer has only submitted safety data for two months, but it typically takes the agency six months for full approval. The vaccine has been approved for people aged 16 and over.

On Friday, FDA Commissioner Stephen Hahn said the agency was “working fast” to clear the vaccine in case of emergency. Shortly after Hahn testified, Trump, who has repeatedly said he had urged the FDA to move faster in the vaccine development process, told the agency in a tweet: “Get the dam vaccines out NOW.”

The FDA’s announcement comes after a key agency advisory body voted 17 to 4, with one abstention, to recommend the vaccine for emergency approval on Thursday. The Advisory Committee on Vaccines and Related Biological Products plays a key role in approving influenza and other vaccines in the United States and verifying that the vaccines are safe for public use. While the FDA does not need to follow the advisory board’s recommendation, it often does.

FDA approval marks a record breaking time frame for a process that typically takes about a decade. The fastest vaccine development to date against mumps took more than four years and was licensed in 1967. Pfizer and BioNTech announced plans to develop a coronavirus vaccine in March and filed an emergency clearance application with the FDA in November. Health authorities in Canada, the UK and Bahrain have approved Pfizer’s vaccine for most adults.

Pfizer’s vaccine uses messenger RNA or mRNA technology. It’s a new approach to vaccines that uses genetic material to trigger an immune response. Moderna, another front runner in the Covid vaccine race, also uses mRNA technology. Late-stage clinical trial data shows Pfizer’s vaccine is 95% effective against Covid, safe, and appears to ward off serious illness. For maximum effectiveness, the vaccine requires two doses about 21 days apart.

Pfizer’s vaccine requires a storage temperature of minus 94 degrees Fahrenheit, which poses potential logistical challenges for rural areas and inner cities that may not have good health infrastructure. For comparison: According to Moderna, the vaccine can be stored for up to six months at minus 4 degrees Fahrenheit.

FedEx and United Parcel Service on Thursday expressed confidence in their networks to distribute the vaccines across the country in a Senate hearing and outlined plans to monitor the location and temperatures of the shipments.

The Federal Aviation Administration asked the airports late Friday to ensure that they have adequate staff when the vaccines arrive. In a statement hours before the vaccine was approved, the FAA said airports should consider providing areas for trucks for vaccines to be picked up on arrival. The agency has announced that flights with cans and related supplies will be given priority.

U.S. officials plan to continue to monitor for side effects of the Pfizer vaccine among the health care workers and nursing homes who receive it, said Dr. Nancy Messonnier, director of the CDC’s National Center for Immunization and Respiratory Diseases, during the agency’s meeting on Thursday. The officers will use an SMS system called v-safe, which is designed to provide early warning of possible side effects of the vaccine.

During the meeting, FDA vaccine reviewer Dr. Susan Wollersheim found that the study data showed a “numerical imbalance” in Bell’s palsy, a condition that causes temporary weakness or paralysis of the muscles in the face. She said there were four cases in the vaccine group and none in the placebo group. Although the frequency of the cases was inconsistent with the general population, the FDA recommended further monitoring once the vaccine becomes more widely distributed.

Read the full letter from the FDA below: